Table 5.
Summary of the typical theranostic platforms based on PDA-modified nanoparticle drug systems.
| Diagnostic tool | Therapeutic method | Theranostic platform | Representative drug system | Ref. |
|---|---|---|---|---|
| MRI | PTT | MRI-PTT | MnCO3@PDA | [62] |
| PDT | MRI-PDT | Ce6@CaCO3−PDA−PEG | [101] | |
| CT | PTT- chemotherapy | CT-PTT- chemotherapy | Bi2Se3@PDA/DOX/HSA | [69] |
| PDT-PTT | CT-PDT-PTT | Au@PDA | [41] | |
| PA | PTT | PA-PTT | Fe3O4@PDA | [43] |
| Optical imaging | PTT- chemotherapy | Optical imaging -PTT- chemotherapy | GNRs@GCS@PDA | [109] |
| Nuclear imaging | PTT- chemotherapy | Nuclear imaging -PTT- chemotherapy | RGD-PEG-125I/Pt-PDA@GNR | [48] |